130 related articles for article (PubMed ID: 38759423)
1. Neuromyelitis optica spectrum disorders registry system in Iran: Validity of data sets.
Khodaie F; Lapevandani MM; Ebrahimi Y; Sahraian MA; Moghadasi AN; Ayoubi S; Goudarzi H; Paybast S; Kamyari N; Asgari N; Fujihara K; Heidari H; Eskandarieh S
Mult Scler Relat Disord; 2024 Jul; 87():105685. PubMed ID: 38759423
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set.
Shahin S; Eskandarieh S; Moghadasi AN; Razazian N; Baghbanian SM; Ashtari F; Bayati A; Manouchehrinia A; Beiki O; Mohebi F; Dezfuli MM; Sahraian MA
Mult Scler Relat Disord; 2019 Aug; 33():158-161. PubMed ID: 31203146
[TBL] [Abstract][Full Text] [Related]
3. Development, validation, and pilot implementation of the minimum datasheet for a domestic violence registry system: The case of a developing country.
Iezadi S; Gholipour K; Khanijahani A; Alizadeh M; Samadirad B; Azizi H; Azizinia F
PLoS One; 2021; 16(12):e0261460. PubMed ID: 34972149
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica spectrum disorders in Iran.
Eskandarieh S; Nedjat S; Azimi AR; Moghadasi AN; Sahraian MA
Mult Scler Relat Disord; 2017 Nov; 18():209-212. PubMed ID: 29141812
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Rojas JI; Alonso Serena M; Garcea O; Patrucco L; Carrá A; Correale J; Vrech C; Pappolla A; Miguez J; Doldan ML; Silveira F; Alonso R; Cohen L; Pita C; Silva BA; Fiol M; Gaitán MI; Marrodan M; Negrotto L; Ysrraelit MC; Deri N; Luetic G; Caride A; Carnero Contentti E; Lopez PA; Pettinicchi JP; Curbelo C; Martinez AD; Steinberg JD; Balbuena ME; Tkachuk V; Burgos M; Knorre E; Leguizamon F; Piedrabuena R; Liwacki SDV; Barboza AG; Nofal P; Volman G; Alvez Pinheiro A; Hryb J; Tavolini D; Blaya PA; Silva E; Blanche J; Tizio S; Caceres F; Saladino ML; Zanga G; Fracaro ME; Sgrilli G; Pagani Cassara F; Vazquez G; Sinay V; Menichini ML; Lazaro L; Cabrera LM; Bestoso S; Divi P; Jacobo M; Kohler E; Kohler M; Giunta D; Mainella C; Manzi R; Parada Marcilla M; Viglione JP; Martos I; Reich E; Jose G; Cristiano E; Fernández Liguori N;
Neurol Sci; 2020 Jun; 41(6):1513-1519. PubMed ID: 31960250
[TBL] [Abstract][Full Text] [Related]
6. Late-onset neuromyelitis optica spectrum disorder: A case series from Iran.
Ghadiri F; Eskandarieh S; Sahraian MA; Azimi A; Moghadasi AN
Rev Neurol (Paris); 2022 Mar; 178(3):249-252. PubMed ID: 34776261
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.
Sahraian MA; Moghadasi AN; Azimi AR; Asgari N; H Akhoundi F; Abolfazli R; Alaie S; Ashtari F; Ayromlou H; Baghbanian SM; Moghadam NB; Fatehi F; Foroughipour M; Langroodi HG; Majdinasab N; Nickseresht A; Nourian A; Shaygannejad V; Torabi HR
Mult Scler Relat Disord; 2017 Nov; 18():144-151. PubMed ID: 29141797
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic and clinical characteristics of neuromyelitis optica spectrum disorder patients, A seven years follow-up study from Iran.
Ashtari F; Mehdipour R; Eini A; Ghalamkari A
Mult Scler Relat Disord; 2023 Sep; 77():104852. PubMed ID: 37399672
[TBL] [Abstract][Full Text] [Related]
9. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.
Rafiee F; Tarjoman T; Moghadasi AN; Sahraian MA; Azimi A; Rezaeimanesh N; Eskandarieh S
Mult Scler Relat Disord; 2020 Nov; 46():102544. PubMed ID: 33032056
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
[TBL] [Abstract][Full Text] [Related]
11. Designing a minimum dataset for autism spectrum disorder registry in Iran.
Shayestehfar M; Jahandideh P; Hariri R; Shayestehfar M; Memari A
Ann Med Surg (Lond); 2023 May; 85(5):2273-2277. PubMed ID: 37228966
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998-2008, 2007-2014).
Asgari N; Lillevang ST; Skejoe HPB; Kyvik KO
Brain Behav; 2019 Jul; 9(7):e01338. PubMed ID: 31187587
[TBL] [Abstract][Full Text] [Related]
14. Exploring the association of reproductive history with the development and course of neuromyelitis optica spectrum disorder.
Hadinejad M; Masoudi M; Sahraian MA; Mozdabadi RSK; Aliabadi HR; Shahmohammadi S; Rezaeimanesh N; Moghadasi AN
Clin Neurol Neurosurg; 2022 Aug; 219():107342. PubMed ID: 35777180
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorder and menstruation.
Badihian S; Manouchehri N; Mirmosayyeb O; Ashtari F; Shaygannejad V
Rev Neurol (Paris); 2018 Dec; 174(10):716-721. PubMed ID: 30049560
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
Rajput HM; Hassan M; Badshah M
Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
[TBL] [Abstract][Full Text] [Related]
18. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a customized checklist to assess the quality control of disease registry systems of Tehran, the capital of Iran in 2021.
Barzin M; Sabbaghi H; Kamfar S; Seifi A; Hajipour M; Siri FH; Mir-Moeini E; Gharajeh A; Ferdosifard N; Panahi M; Nazari SSH; Atatalab FF; Etemad K
BMC Health Serv Res; 2023 Jul; 23(1):726. PubMed ID: 37403074
[TBL] [Abstract][Full Text] [Related]
20. Establishing a minimum data set for suicide and attempted suicide registry system in Iran.
Shafiee M; Shanbehzadeh M; Kazemi-Arpanahi H
BMC Public Health; 2022 Apr; 22(1):857. PubMed ID: 35484542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
